About Bain Capital Life Sciences

Bain Capital Life Sciences was founded in 2016 and builds on Bain Capital’s forty-year history of healthcare and life sciences investing across private equity, public equity, credit, venture capital, and real estate. Bain Capital Life Sciences invests in biopharmaceutical, medical device, diagnostic, and life science tool companies across the globe, with a focus on companies that drive medical innovation to improve the lives of patients with unmet medical needs.

The Bain Capital Life Sciences team has organically grown to more than 20 investment professionals with extensive public and private investing expertise, operating and consulting experience, and colleagues who bring deep scientific and medical insights. The team’s differentiated skillset enables Bain Capital Life Sciences to invest scale capital and provide value-added strategic support to clinical and commercial-stage companies around critical phases of value creation.

By the Numbers

$06.0B
ASSETS UNDER MANAGEMENT
048
INVESTMENTS

Globally, across diagnostics & life sciences tools, medical devices, and biotechnology & pharmaceuticals

0100+
TRIALS FUNDED

To help improve the lives of patients with unmet medical needs

040+
BOARD POSITIONS

from the start of investment

All figures as of September 30, 2024 unless otherwise noted.

Bain Capital Healthcare

We have built one of the largest and deepest healthcare investing teams in the world. Click here to read more about the breadth and legacy of our efforts.